SCHEMBL23867509

SCHEMBL23867509

Cc1cc(Nc2ccc(C(=O)Nc3c[nH]c4ccccc34)cc2)nc(N2CCCC2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 6/20 0.50
▸ CDK2 P24941 6/20 0.50
▸ LMNA P02545 2/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ HPGD P15428 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ DNMT1 P26358 4/20 0.44
▸ DNMT3L Q9UJW3 3/20 0.44
▸ DNMT3A Q9Y6K1 3/20 0.44
▸ MYC P01106 1/20 0.44
▸ MAP2K3 P46734 1/20 0.44
▸ EHMT2 Q96KQ7 1/20 0.44
▸ EHMT1 Q9H9B1 1/20 0.44
▸ DNMT3B Q9UBC3 1/20 0.44
▸ MAPT P10636 1/20 0.43
▸ STING1 Q86WV6 3/20 0.43
▸ GALR2 O43603 2/20 0.42
▸ ROCK2 O75116 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23867578 0.89 HTR1A (0.48) CCNE1CDK2LMNAKDM4EALDH1A1
SCHEMBL23859943 0.85 HRH3 (0.53) CCNE1CDK2LMNAKDM4EALDH1A1
SCHEMBL30165658 0.85 HRH3 (0.53) CCNE1CDK2LMNAKDM4EALDH1A1
SCHEMBL30979651 0.80 SLC2A1 (0.51) LMNAKDM4EALDH1A1MAPT
SCHEMBL30234151 0.80 IMPDH2 (0.46) CCNE1CDK2LMNAKDM4EALDH1A1
SCHEMBL23867521 0.76 HTR1A (0.50) CCNE1CDK2LMNAKDM4EALDH1A1
SCHEMBL23867572 0.75 ACHE (0.48) CCNE1CDK2LMNA
SCHEMBL23867523 0.75 SLC2A1 (0.49) CCNE1CDK2LMNAKDM4EALDH1A1
SCHEMBL30234371 0.75 ROCK1 (0.46) CCNE1CDK2LMNAKDM4EALDH1A1
SCHEMBL31094225 0.75 CCNE1 (0.49) CCNE1CDK2LMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195279-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-09-30 — — WO disclosed
Send feedback